Sanofi-Aventis estende prazo da oferta de compra da Genzyme Mais de 18 mil milhões de euros é quanto a Sanofi-Aventis oferece pela Genzyme até ao dia 15 de Fevereiro.
2011-01-24 15:31
<p><img src="http://feedads.g.doubleclick.net/~a/U5zJufDhrBUBfW_tHEOCO4uEwh4/0/di" border="0" ismap="true"></img> (http://feedads.g.doubleclick.net/~a/U5zJufDhrBUBfW_tHEOCO4uEwh4/0/da)
<img src="http://feedads.g.doubleclick.net/~a/U5zJufDhrBUBfW_tHEOCO4uEwh4/1/di" border="0" ismap="true"></img> (http://feedads.g.doubleclick.net/~a/U5zJufDhrBUBfW_tHEOCO4uEwh4/1/da)</p><img src="http://feeds.feedburner.com/~r/jornaldenegocios/XJkD/~4/h-2Q3Mwr780" height="1" width="1"/>
http://feedproxy.google.com/~r/jornaldenegocios/XJkD/~3/h-2Q3Mwr780/index.php